Viewing nowSaporrelis Extended-Release Tablets 300 mg (Sarpogrelate Hydrochloride)
Sarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
CTC Bio Co., Ltd.

MFDS item code 202003676 · Approved 2020.05.21 · Insurance code 669502670
Improvement of ischemic symptoms (ulcers, pain, etc.) due to chronic arterial obstruction
This medication is used to improve ischemic symptoms such as ulcers, pain, and coldness caused by inadequate blood circulation due to chronic arterial obstruction. Representative diseases include Buerger's disease, obstructive arteriosclerosis, and diabetic peripheral vascular disease. It helps improve blood flow and alleviate symptoms for patients with vascular conditions, reducing discomfort in daily life. Thus, it is effective in treating ischemic symptoms caused by chronic peripheral vascular diseases.
Administer Sarpogrelate Hydrochloride extended-release tablets 300 mg orally once daily after meals. This medication should be taken whole without chewing or crushing.
This medication should not be administered to patients with bleeding as it may increase the risk of bleeding. It is also safe not to use in women who are pregnant or may become pregnant. Caution should be exercised when administering to women during menstruation, patients with a tendency to bleed, and those taking anticoagulants or antiplatelet agents. Patients with severely impaired kidney function or the elderly also require careful attention. Various side effects such as rash, dyspepsia, headache, and cough may occur while taking this medication, so any unusual symptoms should be reported immediately. In particular, if bleeding symptoms, blood abnormalities, or hepatic function abnormalities occur, administration should be stopped immediately and medical consultation should be sought. Regular blood tests are recommended during the use of this medication, and caution should be taken as the risk of bleeding may increase when taken with other anticoagulants or antiplatelet agents. It is preferable for women who are pregnant or breastfeeding not to use this medication; if necessary, breastfeeding should be avoided. Safety has not been established for pediatric patients, and there is no usage experience in children. This medication should be kept out of reach of children, and transferring to other containers is discouraged to maintain quality.
Urticaria, chest pain, difficulty breathing, difficulty urinating, bleeding (gastrointestinal bleeding, intracranial bleeding, subcutaneous bleeding), agranulocytosis, anemia, thrombocytopenia, leukopenia, acute hepatitis, hepatic dysfunction, jaundice, severe allergic reactions, severe skin reactions, serious neurological symptoms, severe edema or urination abnormalities
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. It is advisable to store it at room temperature between 1 to 30 degrees Celsius.
White rectangular film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
CTC Bio Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Yuhan Corporation

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
(Co., Ltd.) Pharmgen Science

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Haewon Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Allico Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.